Constellation Software: 3Q26 Recap
Welcome to Speedwell Memos. Our main website is SpeedwellResearch.com . This is a business update on a company we have previously written an in-depth research report on . To read the full research report become a member today . Members get access all of our research reports and all prior updates (most of which are paywalled). You can see a list of all the companies we have written on here . Subscribe now (Note: This is a Business Recap, which is shorter than our Business Updates. Members can download a PDF here ) 3Q26 Update. Constellation Software reported 3Q26 earnings, and the stock fell -8% in response before partially recovering over the next few days. The ADR (CNSWF) is now +1.5% YTD after being down as much as 30% during the year. Revenues grew +19% y/y, which is a slight acceleration from last quarter’s +17% y/y. Organic revenue grew +2% y/y, which is an improvement from 1% last Q. However, the aggregated organic revenue growth figures give us limited information. It makes more sense to hone in on their Maintenance & Other recurring revenue, (which is the best barometer of the health of their core software business), which was +4% y/y. However, if you back out US healthcare (namely Altera), management noted that Maintenance & Other recurring revenue growth would have been +5%. Mark Miller described this as a normal quarter within the 5-7% range they have seen since 2016, albeit at the low end. Altera declined -8% in 3Q, which has improved from last quarter’s decline of -19%. The shrinkage in Altera is attributed to the departure of several large clients, and they expect this business to stabilize by the end of 2027. In the quarter, U.S. healthcare was down -10%, which is much lower than -1% last quarter. They say that most of this decline is attributed to two new healthcare businesses they acquired and when they acquired them, they expected them to shrink. Mark Miller emphasized that this was in their models and both businesses are still on trajectory to meet their IRR expectations. If you exclude those two businesses, the healthcare group would have declined -3% overall instead of -10%. The Altera example is a reminder that Constellation Software focuses on IRR over organic growth. If they pay a cheap enough price for a business and can harvest enough cash from it, it can be a good investment despite the contraction in revenues. Putting pressure on total organic revenue growth was their license business which was down -17% y/y. This is their legacy business that is shrinking as more businesses move to a recurring model, but this was a tougher comp over last year’s +17% growth. Overall, the 2% total organic growth is in the range of what we would expect for them. In our original report, we estimated 0-2% long-term growth, so they are still meeting the high end of that. One lever that we have mentioned that would help them to accelerate organic growth is AI. On the call, Mark Miller noted that all of their businesses are sharing best practices when it comes to AI, but most of the spend in terms of AI hasn’t shown up in their financials. They will continue to experiment within their businesses and be a fast follower when something is working for a company. As AI allows them to create a lot more features and customization for a customer, we are optimistic that this could eventually lead to increased growth. Offsetting that though is that they may feel they have less pricing power on software improvements and instead feel that improving the product could be more defensive. While we still don’t think the average customer will want to rip out their mission critical software and take on developing features and maintaining it themselves, the threat of it might make them more conservative on price hikes. Every business unit though makes these decisions for themselves, and with over 1,600 businesses it is hard to generalize. Turning to capital deployed, CSU deployed $609mn in 3Q26 and has already deployed $673mn QTD, which puts YTD capital deployment at ~$3bn. This continues to be a bright spot for them as of late because it shows that they are continuing to see opportunities to deploy capital. They noted that when they are looking to acquire businesses outside of their core VMS acquisitions, they add a wider set of assumptions to 4 financial models they run. FCFA2S is the best indicator of owner earnings and FCFA2S (after backing out the IRGA liability) grew +2.8% y/y for the quarter. The reason FCFA2S lagged this quarter primarily has to do with changes in working capital, adding back which FCFA2S would have grown 21%. CFO Jamal Baksh commented on working capital below. LTM adjusted FCFA2S is ~$2.25bn, +10% y/y. Adding back working capital gets growth to 16% y/y, in line with our long-term expectations. A secondary factor is that acquisitions initially weigh on their cash flow margins. They noted their 1Q cohort of acquisitions ran a 16% margin and are now up to 27%. The 2Q cohort already went from 12% to 21%. So while the margin hit is short lived, the more companies they acquire, the more it impacts their results. This doesn’t include their PEMS, or Permanent Engaged Minority Shareholdings, but PEMS weren’t meaningful this quarter as it only grew +$11mn q/q in investment in associates. For further reading, check out our Constellation Software Extensive Research Report . Become a Speedwell Research Member The Synopsis Podcast. Follow our Podcast below! Follow Spotify Follow Apple Watch on YouTube Become a Speedwell Research Member to receive our all of our other research reports , business updates , and Plus members also receive Excels . Check out our full coverage below! Become a Speedwell Research Member (Many members have gotten their memberships expensed. If you need us to talk with your compliance department to become an approved vendor, please reach out at info@speedwellresearch.com). If you aren’t ready to become a paying member, drop your email below to receive our free content! *At the time of this writing, one or more contributors to this report may have a position in stocks mentioned. Furthermore, accounts one or more contributors advise on may also have positions in stocks mentioned. This may change without notice.